Stephen Donnelly (Wicklow, Fianna Fail) | Oireachtas source

I have a question on that. I was going through the process on this last week and the view I got was that the clinical evaluation is quite open and moves at a decent clip. The National Centre for Pharmacoeconomics, whether one agrees or disagrees with what it decides, arrives at a recommendation quite quickly. It has its €45,000 per year measure, with which we can agree or disagree, but it is there and the centre moves through that quite quickly.

Their recommendation goes into the HSE or the Department and at that point it becomes completely opaque. Does that sound about right to the officials or would they describe it differently?